IBDEI0A8 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4793,1,2,0)
 ;;=2^32555
 ;;^UTILITY(U,$J,358.3,4793,1,3,0)
 ;;=3^THORACENTESIS,NEEDLE/CATH W/ IMAGING
 ;;^UTILITY(U,$J,358.3,4794,0)
 ;;=J3535^^39^461^10^^^^1
 ;;^UTILITY(U,$J,358.3,4794,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4794,1,2,0)
 ;;=2^J3535
 ;;^UTILITY(U,$J,358.3,4794,1,3,0)
 ;;=3^DRUG ADMIN THRU METERED DOSE INHALER
 ;;^UTILITY(U,$J,358.3,4795,0)
 ;;=J7608^^39^461^1^^^^1
 ;;^UTILITY(U,$J,358.3,4795,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4795,1,2,0)
 ;;=2^J7608
 ;;^UTILITY(U,$J,358.3,4795,1,3,0)
 ;;=3^ACETYLCYSTEINE,INHALE,NON-COMPD,UNIT DOSE
 ;;^UTILITY(U,$J,358.3,4796,0)
 ;;=J7609^^39^461^3^^^^1
 ;;^UTILITY(U,$J,358.3,4796,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4796,1,2,0)
 ;;=2^J7609
 ;;^UTILITY(U,$J,358.3,4796,1,3,0)
 ;;=3^ALBUTEROL,INHALE,COMPD,UNIT DOSE 1MG
 ;;^UTILITY(U,$J,358.3,4797,0)
 ;;=J7610^^39^461^2^^^^1
 ;;^UTILITY(U,$J,358.3,4797,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4797,1,2,0)
 ;;=2^J7610
 ;;^UTILITY(U,$J,358.3,4797,1,3,0)
 ;;=3^ALBUTEROL,INHALE,COMPD,CONCENTRATE FRM 1MG
 ;;^UTILITY(U,$J,358.3,4798,0)
 ;;=J7613^^39^461^5^^^^1
 ;;^UTILITY(U,$J,358.3,4798,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4798,1,2,0)
 ;;=2^J7613
 ;;^UTILITY(U,$J,358.3,4798,1,3,0)
 ;;=3^ALBUTEROL,INHALE,NON-COMPD,UNIT DOSE 1MG
 ;;^UTILITY(U,$J,358.3,4799,0)
 ;;=J7611^^39^461^4^^^^1
 ;;^UTILITY(U,$J,358.3,4799,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4799,1,2,0)
 ;;=2^J7611
 ;;^UTILITY(U,$J,358.3,4799,1,3,0)
 ;;=3^ALBUTEROL,INHALE,NON-COMPD,CONCENTRATE FRM 1MG
 ;;^UTILITY(U,$J,358.3,4800,0)
 ;;=J7644^^39^461^15^^^^1
 ;;^UTILITY(U,$J,358.3,4800,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4800,1,2,0)
 ;;=2^J7644
 ;;^UTILITY(U,$J,358.3,4800,1,3,0)
 ;;=3^IPRATROPIUM BROMIDE INHALE,NON-COMPD,UNIT PER MG
 ;;^UTILITY(U,$J,358.3,4801,0)
 ;;=30906^^39^461^8^^^^1
 ;;^UTILITY(U,$J,358.3,4801,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4801,1,2,0)
 ;;=2^30906
 ;;^UTILITY(U,$J,358.3,4801,1,3,0)
 ;;=3^CONTROL NOSEBLEED,POST W/ PACKS/CAUTERY;SUBSQ
 ;;^UTILITY(U,$J,358.3,4802,0)
 ;;=33010^^39^462^14^^^^1
 ;;^UTILITY(U,$J,358.3,4802,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4802,1,2,0)
 ;;=2^33010
 ;;^UTILITY(U,$J,358.3,4802,1,3,0)
 ;;=3^PERICARDIOCENTESIS,INIT
 ;;^UTILITY(U,$J,358.3,4803,0)
 ;;=33210^^39^462^13^^^^1
 ;;^UTILITY(U,$J,358.3,4803,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4803,1,2,0)
 ;;=2^33210
 ;;^UTILITY(U,$J,358.3,4803,1,3,0)
 ;;=3^PACING,TRANSVENOUS(TEMP)
 ;;^UTILITY(U,$J,358.3,4804,0)
 ;;=36000^^39^462^11^^^^1
 ;;^UTILITY(U,$J,358.3,4804,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4804,1,2,0)
 ;;=2^36000
 ;;^UTILITY(U,$J,358.3,4804,1,3,0)
 ;;=3^IV INSERTION,VEIN
 ;;^UTILITY(U,$J,358.3,4805,0)
 ;;=36011^^39^462^10^^^^1
 ;;^UTILITY(U,$J,358.3,4805,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4805,1,2,0)
 ;;=2^36011
 ;;^UTILITY(U,$J,358.3,4805,1,3,0)
 ;;=3^IV INSERTION,JUGULAR OR FEMORAL
 ;;^UTILITY(U,$J,358.3,4806,0)
 ;;=36556^^39^462^3^^^^1
 ;;^UTILITY(U,$J,358.3,4806,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4806,1,2,0)
 ;;=2^36556
 ;;^UTILITY(U,$J,358.3,4806,1,3,0)
 ;;=3^CENTRAL VENOUS LINE
 ;;^UTILITY(U,$J,358.3,4807,0)
 ;;=36600^^39^462^2^^^^1
 ;;^UTILITY(U,$J,358.3,4807,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4807,1,2,0)
 ;;=2^36600
 ;;^UTILITY(U,$J,358.3,4807,1,3,0)
 ;;=3^ARTERIAL PUNCTURE (ABG)
 ;;^UTILITY(U,$J,358.3,4808,0)
 ;;=36620^^39^462^1^^^^1
 ;;^UTILITY(U,$J,358.3,4808,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4808,1,2,0)
 ;;=2^36620
 ;;^UTILITY(U,$J,358.3,4808,1,3,0)
 ;;=3^ARTERIAL CATHETER PERCUTANEOUS
